Investor Information

Press Releases

Perma Fix Medical plans to submit both FDA and CE applications in the first half of 2017 – Interview with Steve Belcher, CEO (Polish newspaper Parkiet)
January 17, 2017

Perma-Fix Medical Announces Preliminary Agreement with Acsion Industries to Support Development a New Technetium-99 Generator
December 6, 2016

Perma-Fix Medical Announces Letter of Intent for Certain Proposed Funding of its Wholly Owned Subsidiary
October 17, 2016

Perma-Fix Awarded Key Patent for its Microporous Composite Material in Eurasia
September 9, 2016

Perma-Fix Medical Provides Business Update
September 1, 2016

Perma-Fix Medical- From NewConnect to Nasdaq ‐ Interview with Stephen Belcher, CEO (Polish)
April 24, 2016

Perma-Fix Medical Provides Business Update
April 14, 2016

Perma-Fix Medical Schedules Business Update Conference Call
April 7, 2016

Perma-Fix Medical Announces Plans to List on NASDAQ
April 4, 2016

Perma-Fix Medical S.A. Formally Accepts $2.8 Million Grant Awarded Earlier This Year to Advance Development of Technetium Generator for Cancer and Cardiac Imaging
December 28, 2015

Perma-Fix Medical Expands Senior Management Team and Supervisory Board. Perma Fix Medical appoints Ben Naccarato as Management Board member and Matthew Molchan as Supervisory Board member
December 23, 2015

Perma-Fix Medical Provides Business Update
November 19, 2015

Perma Fix Medical plans to submit both FDA and CE applications early 2016 – Interview with Steve Belcher, CEO (Polish)
November 18, 2015

Perma-Fix Medical expects the start of uplisting process to Main Market of Warsaw Stock Exchange before year-end and considers dual listing on Nasdaq – Interview with Steve Belcher, CEO (Polish)
November 18, 2015

Perma-Fix Medical Schedules Business Update Conference Call
November 12, 2015

Perma-Fix Medical Chairman to Speak at the National Academies of Sciences, Engineering and Medicine - Nuclear and Radiation Studies Board Committee Meeting in Washington, DC
October 28, 2015

Perma-Fix Medical Announces Successful Completion of 6 Curie Tests with ScaleUp of its Non-Uranium Process to Procure Technetium-99m
September 2, 2015

Perma-Fix Medical Provides Business Update
August 25, 2015

Perma-Fix Medical Schedules Business Update Conference Call
August 21, 2015

Perma-Fix Medical announces that it has completed its Strategic Partnership and Investment from Digirad Corporation
July 27, 2015

Perma Fix Medical Ranked Fifth Most Popular NewConnect Listed Investment Choice of Polish Fund Managers
June 16, 2015

Perma-Fix Medical Confirms Successful Tests at 4 Curie Level; Achieves Another Major Milestone Towards Scale-Up of Non-Uranium Process to Produce Technetium-99m
June 15, 2015

Perma-Fix Medical S.A to Present at SeeThruEquity First Annual Warsaw Investor Conference
June 10, 2015

Perma-Fix Medical Expands Senior Management Team and Supervisory Board
June 10, 2015

Perma-Fix Medical to Present at 3rd Global Life Sciences Conference in Warsaw
June 9, 2015

Perma-Fix Medical Announces Important Milestone Towards Scale-Up of Non-Uranium Process to Produce Technetium-99m
June 9, 2015

Perma-Fix Medical Provides Business Update
May 26, 2015

Perma-Fix Medical Schedules Business Update Conference Call
May 22, 2015

Perma-Fix Medical Provides Business Update
March 26, 2015

Perma-Fix Medical Schedules Business Update Conference Call
March 17, 2015

Perma-Fix Medical CEO Dr. Louis F. Centofanti Appointed to Department of Commerce’s Civil Nuclear Trade Advisory Committee
March 16, 2015

Perma-Fix Medical Project Awarded $2.7 Million Grant to Advance Development of Technetium Generator for Cancer and Cardiac Imaging
January 21, 2015

Perma-Fix Medical Announces that it has entered into a Letter of Intent as to a Planned Strategic Partnership and Investment from Digirad Corporation
January 16, 2015

US Patent Office Issues Patent to Perma-Fix for Microporous Composite Material and Its Applications
January 5, 2015

Perma-Fix Medical Provides Business Update
November 19, 2014

Perma-Fix Medical Schedules Business Update Conference Call
November 17, 2014

Perma-Fix Medical to Present at 2nd global Life Sciences Conference in Warsaw
September 23, 2014

US Patent Office Issues Notice of Allowance to Perma-Fix Allowing All Claims of Patent Application for Preparation of Microporous Composite Material and Its Applications
August 27, 2014

Dr. Centofanti to Present Perma-Fix Medical's Tc-99m Production Process at the 8th International Conference on Isotopes and Expo
August 25, 2014

Perma-Fix Medical Provides Business Update
August 18, 2014, 3:00 PM EDT

Perma-Fix Medical Schedules Business Update Conference Call
August 15, 2014

Perma-Fix Medical Completes Financing with European Investors
August 11, 2014

Perma-Fix to Present at NNSA's 2014 Mo-99 Conference
June 26, 2014, 2:06 PM EDT

Leading Nuclear Medicine Industry Executive Stephen Belcher Joins Perma-Fix Medical Advisory Board
June 10, 2014, 7:30 AM EDT

Perma-Fix to Present at the First Global Energy and Resources Conference in Warsaw
May 28, 2014, 12:00 PM EDT

Perma-Fix Medical Provides Business Update
May 22, 2014, 4:55 PM EDT

Perma-Fix Medical Schedules Business Update Conference Call
Click here to listen to the webcast on Friday, May 23 at 8:30 AM Eastern DST, 2:30 p.m. Central European Time
May 20, 2014, 8:18 AM EDT

Perma-Fix Medical Announces Validation of Medical Isotope Technology With Leading International Reactor Operators
Mar 27, 2014, 11:55 AM EDT

Perma-Fix Announces Formation of Medical Isotope Technology Company
Feb 19, 2014, 8:00 AM EST

Perma-Fix Announces Exclusive Commercial License to Technology for Use in Proprietary Process to Produce Medical Isotopes
Dec 10, 2012, 7:30 AM EST

Perma-Fix Signs Option Agreement to License Technology for Use in Proprietary Process to Produce Medical Isotopes
Jun 3, 2011, 9:00 AM EDT